Back to search

National and Kapodistrian University of Athens

Επισήμανση του μονοκλωνικού αντισώματος anti-CEA με Sm-153: ραδιοχημική και ραδιοβιολογική αξιολόγηση

Abstract

dc:description

In the present study the labeling of the monoclonal antibody anti-CEA and of the polyclonal human immunoglobulin Sandoglobuline with the radioisotope 153Sm has been investigated. Samarium-153 (t1/2 = 46.75 h) is mainly a beta emitter (Eβ = 227 keV), which can be used for therapeutic purposes, while its γ-ray (Eγ = 103 keV, 28%) facilitates scintigraphic imaging. Thus, monoclonal antibodies labeled with 153Sm can be used for combined radioimmunoscintigraphy and radioimmunotherapy. Labeling can be achieved using the bicyclic anhydride of DTPA (cDTPAa) as the bifunctional chelating agent, which, when conjugated to antibody molecules, can bind 153Sm. Labeling was performed with the addition of 153Sm, in the form of 153SmCl3 solution, to the Ab-DTPA immunoconjugate solution, at a pH range of 5.0-5.5. The reaction mixture was incubated at room temperature and free 153Sm was eliminated by gel filtration, in a Bio Gel P30 column. The labeling control was performed using a combination of radiochemical techniques (gel filtration, HPLC, ITLC-SG and SDS-PAGE). The factors, which possibly affect the labeling yield, have been investigated, in order to find out those which lead to a final product, obtainable in high yield and with high radiochemical purity. Optimization of factors (pH, Ab, Ab-DTPA concentration etc) leads to a labeling yield > 90%. The final product was obtained in radiochemical purity > 98%, which allows its use for in vivo studies. The anti-CEA-DTPA immunoconjugate was prepared using different concentrations of anti-CEA (3 to 15 mg/ml) and different molar ratios of anti-CEA:cDTPAa (1:3.5 to 1:45). The number of DTPA molecules attached per anti-CEA molecule (DTPA/anti-CEA) was determined and the effect of DTPA conjugation on the antibody molecule was studied with HPLC and SDS-PAGE. The number of DTPA/anti-CEA increases by increasing both the anti-CEA:cDTPAa molar ratio and the antibody concentration. It is obvious that this leads to an increase in labeling yield and in higher specific activity of the final product. However as a consequence, polymer formation takes place. The effect of DTPA conjugation on the in vivo distribution of the labeled antibody was evaluated in normal mice, where the differences in biodistribution were obvious, in cases of polymer species existence. The limitary number of DTPA/anti-CEA, in order to avoid polymer formation, is 1.5 and it corresponds to an anti-CEA concentration of 3 mg/ml and an anti-CEA:cDTPAa molar ratio of 1:10. In order to achieve a final product with high specific activity it is preferable to use 153SmCl3 solution with high specific activity. In the above maximum tolerated conditions the specific activity of the final product reached a maximum value of 1.2 mCi/mg, using 153SmCl3 solution with specific activity of 763 mCi/mg. The in vivo distribution of [153Sm]DTPA-anti-CEA was evaluated in nude mice, bearing experimental tumors, with anatomic and imaging techniques. The tumor was developed after local implantation of Colo 205 cancer cells, expressing carcinoembryonic antigen (CEA). The apparent association constant Ka of [153Sm]DTPA-anti-CEA for this cell line, as determined by Scatchard analysis, is 2 / 107 M-1. A comparative to nude mice biodistribution study was also performed in normal mice, in order to evaluate the effect of tumor existence in the antibody distribution. [153Sm]DTPA-anti-CEA showed slow blood clearance, it was concentrated mainly into the liver, spleen and lungs, while it was excreted through the kidneys. The comparative biodistribution study in normal and nude mice showed no significant differences in the radioactivity concentration levels in healthy tissues, for 4 hours to 2 days post injection. Differences were obvious from 3-5 days post injection, where the values in the above tissues where higher in nude mice compared to normal. An increase in radioactivity concentration in bones with time was also observed, where it was at the same level for the two kind of animals. [153Sm]DTPA-anti-CEA was evaluated in nude mice bearing tumors weighing 0.5 to 2.5 g. Focusing on tumor radioactivity concentration, higher concentration was observed in 0.5-0.8 g tumors compared to those of 1.5-2.5 g, 24 hours post injection. In nude mice bearing tumors of about the same weight tumor uptake increased with time, reaching a maximum value 2 days post injection. The biodistribution results agreed with scintigraphic studies performed on gamma camera. The tumor can be visualized 4-24 hours post injection, but due to the high background, it can be clearly distinguished from the other tissues 2 days post injection.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2003

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fani, Melpomeni
  • Φάνη, Μελπομένη

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21752

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fani, Melpomeni; Φάνη, Μελπομένη. Επισήμανση του μονοκλωνικού αντισώματος anti-CEA με Sm-153: ραδιοχημική και ραδιοβιολογική αξιολόγηση. National and Kapodistrian University of Athens, 2003. http://hdl.handle.net/10442/hedi/21752